Mark G. Kris, MD, FASCO

Articles

Dr. Mark G. Kris on the Future of Lung Cancer

November 19th 2013

Mark G. Kris, MD, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, discusses the future of lung cancer treatment at the 8th Annual New York Lung Cancer Symposium®

Dr. Mark Kris on Performance Status in Lung Cancer

January 9th 2013

Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, discusses the importance of accurately determining a patient's performance status.

Dr. Kris on Dacomitinib in EGFR-Positive Lung Cancer

December 12th 2012

Mark G. Kris, MD, from Memorial Sloan-Kettering Cancer Center, discusses the administration of dacomitinib for patient with EGFR-positive lung cancer.

Dr. Kris Discusses Crizotinib in ALK-Positive Lung Cancer

November 2nd 2012

Mark G. Kris, MD, from Memorial Sloan-Kettering Cancer Center, discusses the results of a phase III trial that studied the use of crizotinib in patients with advanced ALK-positive lung cancer.

Dr. Kris on the Combination of Targeted Therapies

July 6th 2012

Dr. Mark Kris, from Memorial Sloan-Kettering Cancer Center, on the Combination of Molecularly Targeted Therapies.

Dr. Kris Discusses ASCO 2012 Lung Cancer Information

June 18th 2012

Dr. Mark Kris, from Memorial Sloan-Kettering Cancer Center, Discusses Lung Cancer Information Presented at the 2012 ASCO Annual Meeting.

Dr. Kris Discusses Available Targeted Therapies

August 10th 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center Discusses Available Targeted Therapies

Dr. Kris on Patient Acceptance of Mutation Testing

August 2nd 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center Discusses Patient Acceptance of Mutation Testing

Dr. Kris on How the Institutes in His Study Worked Together

July 28th 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center on How the Institutes in the mutlicenter study examining driver mutations Worked Together

Dr. Kris Discusses the Field of Mutation Testing

July 26th 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center Discusses the Field of Mutation Testing

Dr. Kris Explains the Use of Gene Signatures

July 25th 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering cancer center Explains How Gene Signatures are Used

Dr. Kris Discusses Driver Mutations Test False Negatives

July 20th 2011

Dr. Mark G. Kris thoracic chair at Memorial Sloan-Kettering Cancer Center Discusses Driver Mutations Test False Negatives

Dr. Kris on Integrating Driver Mutation Testing Study Results

July 8th 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering on Integrating Driver Mutation Testing Study Results

Dr. Kris Talks About Defining Biomarkers

July 5th 2011

Dr. Mark G. Kris from memorial sloan-kettering Talks About the importance of Defining the broad term Biomarkers

Dr. Kris Describes the Genetic Mutation Screening Study

June 30th 2011

Dr. Mark Kris from MSKCC Describes the Genetic Mutation Screening Multicenter Study

Dr. Kris Discusses Tests Available for Lung Cancer

June 28th 2011

Dr. Kris from Memorial Sloan-Kettering Discusses Tests Available for Lung Cancer

Dr. Kris Discusses the Pemetrexed Trial Results

June 23rd 2011

Dr. Mark Kris from Memorial Sloan-Kettering Cancer Center Discusses the Pemetrexed Clincal Trial Results

Dr. Kris Discusses the Imatinib GIST Clinical Trial

June 20th 2011

Dr. Kris From Memorial Sloan-Kettering Cancer Center Discusses the Imatinib GIST Clinical Trial

Dr. Kris Discusses Methotrexate in ALL

June 14th 2011

Dr Kris From Memorial Sloan-Kettering Cancer Center Discusses Methotrexate in Acute Lymphocytic Leukemia

Dr. Kris on the Use of Genetic Testing in Lung Cancer

June 6th 2011

Dr. Kris From Memorial Sloan-Kettering Cancer Center on the Use of Genetic Testing in Lung Cancer